Pelubiprofen

Add links
Source: Wikipedia, the free encyclopedia.
Pelubiprofen
Clinical data
Trade namesPelubi
Legal status
Legal status
  • Rx in several countries
Identifiers
  • 2-[4-[(E)-(2-Oxocyclohexylidene)methyl]phenyl]propanoic acid
JSmol)
  • CC(C1=CC=C(C=C1)/C=C/2\CCCCC2=O)C(=O)O
  • InChI=1S/C16H18O3/c1-11(16(18)19)13-8-6-12(7-9-13)10-14-4-2-3-5-15(14)17/h6-11H,2-5H2,1H3,(H,18,19)/b14-10+
  • Key:AUZUGWXLBGZUPP-GXDHUFHOSA-N

Pelubiprofen is a nonsteroidal anti-inflammatory drug of the profen class used to treat back pain and osteoarthritis.[1]

Pelubiprofen was developed in South Korea by Daewon Pharmaceuticals and it is marketed in Korea and Russia,[2] among other countries.

Research

Pelubiprofen is being studied for use in combination with eperisone.[3]

Because pelubiprofen has low water solubility, development of salt formulations with better solubility are being studied.[4]

References

  1. ^ "Pelubiprofen". AdisInsight.
  2. ^ "Daewon Pharm wins $3 million deal to export Pelubi to Indonesia". Korea Biomedial Review. September 26, 2023.
  3. ^ "(Eperisone + pelubiprofen) by Daewon Pharmaceutical for Low Back Pain: Likelihood of Approval". pharmaceutical-technology.com. 5 June 2023.
  4. PMID 34070062
    .


Stub icon

This analgesic-related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Pelubiprofen&oldid=1204979392"